Takeda Pharmaceuticals and Eli Lilly hit with a $9,000,000,000.00 billion dollar verdict arising from the sale and distribution of their defective drug, Actos.  Our Actos Lawyers are pleased with the outcome of this case tried by Mark Lanier and we congratulate him and his firm.  Pharmaceutical manufacturers need to be aware of the dangers posed by drugs distributed to consumers–and most importantly, patients need to be warned about these dangers.  

Legal Commentary 

The verdict is staggering and exemplifies what can happen to Corporations that place Profit over the safety of Patients.  The case was presented in part on a Failure to Warn theory, as the warning did not adequately inform users of the risk of developing Bladder Cancer arising from Actos use.  As an Actos lawyer, I believe Takeda should have warned about the danger of Actos induced bladder cancer as soon as they had a suspicion that it may harm consumers–this simply did not happen–and it should have.  As a result of this omission, Takeda and Eli Lilly, companies that manufactured, produced and distributed Actos were taken to task by this Jury and will pay for their wrongdoing by having to deal with a $9,000,000,000 verdict.  The consolidated Actos cases in Louisiana are In Re Actos (Pioglitazone) Products Liability Litigation, 11-md-02299. Allen’s case is Allen v. Takeda Pharmaceuticals North America Inc., 12-cv-00064, both in U.S. District Court, Western District of Louisiana (Lafayette).

About the Author

Majed Nachawati is a preeminent Actos Pharmaceutical Products Liability Lawyer with a focus on representing Actos victims and families harmed by dangerous implantations on a nationwide basis—especially the Actos device. Mr. Nachawati has resolved numerous cases through trials and settlements that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati has also been voted as one of only 500 lawyers as one of the Best Mass Tort Lawyers in Dallas by D Magazine. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

 

The number of filed Actos (pioglitazone) lawsuits is on pace to pass the 10,000 mark, according to some legal analysts. The rise in filings is attributed to the dramatic findings of a few key surveys.

 

The manufacturer of Actos recently announced the mid-period findings of its ten-year review of the drug. The scientists’ verdict was that patients who took Actos for longer than one-year experienced a forty percent higher probability of developing bladder cancer. Additionally, the U.S. Food and Drug Administration (FDA) concluded that the possibility for congestive heart failure was sufficiently high to justify a black-box warning.

 

The reason that Actos filings are trending upwards isn’t simply because the findings came to light. It’s that these findings came to light years after Actos was first released onto the market in 1999 and before the drug manufacturer was sufficiently warning the public and health care providers about the risk of harm.

 

Want to know whether filing an Actos lawsuit is right for you or your family? Talk to the professionals at Fears Nachawati today. With years of experience and dedicated expertise, we know how to advise you properly. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to fight for your rights.

For thousands of families, Actos (pioglitazone) isn’t simply a medication. It’s a painful reminder of the hope they felt and the tragedy they have endured.

 

Observers estimate that as many as 10,000 patients will ultimately file lawsuits in defense of their legal rights. Why? During the last several years, medical research has made it increasingly clear that the medication that patients and medical professionals hoped would forestall the effects of Type 2 diabetes actually made life worse for some patients, not better. Specifically, a large and growing number of long-term Actos users and their families have reported side effects that caused bladder complications, including cancer.

 

For many families, the litigation associated with their loved one’s injury may last longer than the victim’s remaining life. Where this is the case, it’s important that everyone understand his or her motivation for filing a suit. Yes, it may the financial rewards that come with a successful negotiation or verdict. However, it may also be a desire to hold the drug manufacturer accountable or to warn other patients about the drug.

 

Knowing your motivation is key to achieving the legal outcome you desire. Is it time to fight for your family’s rights? Talk to the Actos professionals at Fears Nachawati. With years fighting for the legal interests of victims, we know how to protect you and your family. For a free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com

Thousands of Actos (pioglitazone) patients are taking action. Faced with bladder cancer and other bladder-related health conditions, these men and women have asked tough questions about why they’ve experienced what they’ve experienced. In a tragic number of instances, the answer that they’ve found is that long-term exposure to Actos has resulted in serious adverse health effects.

 

The role of Actos in bladder cancer isn’t a complete surprise. In 2011, the French and German health agencies took strong actions to limit the availability of Actos in their markets. Shortly after these steps, the U.S. Food and Drug Administration (FDA) required new labeling, but stopped short of a limitation on the drug’s supply.

 

Regardless of the precise decision, the actions of the French, German, and American health agencies suggest that at the very least patients were insufficiently informed about the true risks associated with this widely prescribed Type 2 diabetes treatment. In response, many patients took action by finding out about the effect of Actos on their health as well as on their legal rights.

 

Want to find out more information about Actos and its potential effect on your rights? The attorneys at the Dallas law firm of Fears Nachawati are prepared to advise you. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com

Pioglitazone-based treatments for Type 2 diabetes, such as the drug Actos, attempt to provide a solution for suffering patients. The trouble is that they also can cause serious problems.

 

Specifically, after about one year of taking Actos, a notable number of patients have reported a dramatically increased probability of experiencing bladder-related issues, including bladder cancer. One study determined that the risk spike for these Actos patients was as high as 40 percent. As a result of these kinds of findings, health agencies in Germany and France have worked to prevent patients from receiving Actos.

 

If your loved one has taken Actos for a prolonged period of time and experienced unusual symptoms such as bladder cancer, it may be time to call the dedicated professionals at the law firm of Fears Nachawati. With years of experience handling these kinds of issues, we know the questions to ask, the answers to seek, and the evidence to accumulate. Contact our dedicated attorneys today. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. Let us fight for you and your family.

Type 2 diabetes patients have limited options when considering how to manage their medical condition. For many, Actos (pioglitazone) has been an important weapon in their arsenal. Unfortunately, however, Actos isn’t a silver bullet and, what’s worse, may cause some patients to shoot themselves in the foot.

 

In recent years, the Food and Drug Administration (FDA) and the health community have increasingly publicized the side effects associated with Actos. Their reports indicate that for diabetes patients who take Actos for more than one year, the likelihood of developing bladder cancer or similar, related conditions can be as high as 40 percent.

 

When is the right time to take action against the maker of this powerful prescription drug? If you didn’t know about the side effects of Actos when you began treatments and you’ve now begun experiencing bladder-related side effects, it may be time to visit with a dedicated attorney from the law firm of Fears Nachawati. For a free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We can give you the advice you need.

If you’re an Actos (pioglitazone) patient who’s on the fence about whether to ask questions about whether your Actos symptoms may have impacted your legal rights, the safe move is probably to ask your questions. And thanks to our free consultations, what do you have to lose?

 

Unfortunately, long-term Actos patients have reported serious side effects, including bladder cancer. Actos-related risks are so large, in fact, some countries have determined that their doctors should not prescribe this Type 2 diabetes medication. That’s not the case in the United States – and patients continue to deal with Actos complications.

 

Ready to find out about the legal relationship between you and the maker of your Actos treatments? The attorneys at Fears Nachawati are prepared to advise you. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We can help you.

The U.S. Food and Drug Administration (FDA) has imposed a black box warning on Actos (pioglitazone). Why? Because although the risks associated with Actos are relatively mild for short-term patients, long-term patients face a distinctly different – and more dangerous – risk profile.

 

French and German health officials, noting the dramatically increased risk of bladder cancer for patients using Actos for longer than one year, have recommended that their governments remove this powerful Type 2 diabetes medication from the market. In the United States, Actos remains available. However, some patients remain so tragically and unjustly under-informed about the risks this medication may impose that they may have the basis for a lawsuit if they’ve experienced physical harm.

 

Want to find out more information about the risks associated with Actos and the way that those risks may give rise to legal liability? The attorneys at Fears Nachawati can answer your questions and guide your thinking about what to do next. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to fight for you.

If diabetes runs in your family, circumstances may have required you to learn about the challenges of Type 2 diabetes and the medications, including Actos (pioglitazone), necessary to confront this pernicious disease. Sadly, while Actos may offer temporary relief, long-term Actos patients should be aware of the risk of this drug.

 

The U.S. Food and Drug Administration (FDA) has stated emphatically that pioglitazone treatments lasting longer than twelve months have a significantly increased likelihood of causing harm to the patient. In fact, the risk of developing bladder cancer could increase by as much as 40 percent as a result of extended pioglitazone treatments. For this reason, French and German government health advisors have strongly cautioned against Actos.

 

Want to find out what Actos may mean for your family? Your family member’s rights may have been impacted by pioglitazone treatments. To learn more, contact the professionals at Fears Nachawati today. With years of experience, we know how to help you. For a free consultation, call 1.866.545.8364 or email mn@fnlawfirm.com

Actos (pioglitazone) doesn’t simply have risks. This commonly prescribed drug for patients suffering from Type-2 diabetes features a risk spike beginning around the twelfth month of a patient’s treatment. As patients enter a second year of pioglitazone treatments, there probability for suffering from side effects elevates considerably. Bladder cancer, for instance, occurs at a significantly more frequent basis for longer-term consumers.

 

Has your loved one suffered from Actos side effects? If the answer is yes, it may be time to speak with the professionals and dedicated attorneys at Fears Nachawati. With years of experience handling claims like those of your family, we know the questions to ask, the answers to seek, and the evidence to accumulate. Contact our dedicated attorneys today. With years of experience, we know how to protect clients just like you. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com